uniQure NV Hits Day High with 14.81% Surge in Strong Intraday Performance

uniQure NV, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a significant surge in its stock price, gaining 14.81% on May 29, 2026. The stock reached an intraday high of USD 29.48, reflecting strong market activity. Over the past week, uniQure has shown a robust performance with a 17.94% increase, and its one-month performance stands at an impressive 70.53%, significantly outperforming the S&P 500, which recorded a 6.22% gain in the same period. In the past year, uniQure has delivered a remarkable return of 91.48%, far exceeding the S&P 500's 28.21% return. This performance is underpinned by a notable increase in net sales, which grew by 127.31% to USD 3.56 million. However, the company reported a higher net profit loss of USD -91.01 million, indicating ongoing financial challenges. Despite these hurdles, the stock's high institutional holdings at 100% suggest strong confidence from sophisticated investors. Overall, uniQure NV's recent performance highlights its dynamic position within the market, showcasing both growth potential and inherent risks.